1-3412703-G-A
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_022114.4(PRDM16):c.2506G>A(p.Gly836Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000347 in 1,496,222 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. G836G) has been classified as Likely benign.
Frequency
Consequence
NM_022114.4 missense
Scores
Clinical Significance
Conservation
Publications
- left ventricular noncompaction 8Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, Illumina, Labcorp Genetics (formerly Invitae)
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- left ventricular noncompactionInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- dilated cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_022114.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PRDM16 | NM_022114.4 | MANE Select | c.2506G>A | p.Gly836Ser | missense | Exon 9 of 17 | NP_071397.3 | ||
| PRDM16 | NM_199454.3 | c.2506G>A | p.Gly836Ser | missense | Exon 9 of 17 | NP_955533.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PRDM16 | ENST00000270722.10 | TSL:1 MANE Select | c.2506G>A | p.Gly836Ser | missense | Exon 9 of 17 | ENSP00000270722.5 | ||
| PRDM16 | ENST00000378391.6 | TSL:1 | c.2506G>A | p.Gly836Ser | missense | Exon 9 of 17 | ENSP00000367643.2 | ||
| PRDM16 | ENST00000512462.5 | TSL:1 | n.2284G>A | non_coding_transcript_exon | Exon 8 of 16 |
Frequencies
GnomAD3 genomes AF: 0.00156 AC: 238AN: 152154Hom.: 2 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000518 AC: 54AN: 104294 AF XY: 0.000286 show subpopulations
GnomAD4 exome AF: 0.000209 AC: 281AN: 1343950Hom.: 1 Cov.: 35 AF XY: 0.000173 AC XY: 114AN XY: 658034 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00156 AC: 238AN: 152272Hom.: 2 Cov.: 33 AF XY: 0.00142 AC XY: 106AN XY: 74454 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:6
PRDM16: BP4, BS1
not specified Benign:2
Gly836Ser in exon 9 of PRDM16: This variant is not expected to have clinical sig nificance because it has been identified in 3.4% (6/176) of Yoruba (Nigerian) ch romosomes from a broad population by the 1000 Genomes Project (http://www.ncbi.n lm.nih.gov/projects/SNP; dbSNP rs114204766).
Inborn genetic diseases Uncertain:1
The c.2506G>A (p.G836S) alteration is located in exon 9 (coding exon 9) of the PRDM16 gene. This alteration results from a G to A substitution at nucleotide position 2506, causing the glycine (G) at amino acid position 836 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
PRDM16-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Left ventricular noncompaction 8 Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at